EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liposome Encapsulation Enhances Ripasudil Therapeutic Efficacy Against Proliferative Vitreoretinal Diseases: Implications in Advanced Ocular Treatment

Rui Ji, Keijiro Ishikawa, Wei Tan, Kenichiro Mori, Ryotaro Tsukamoto, Naoya Matsunaga, Kohei Kiyohara, Yosuke Fukuda, Iori Wada, Tomoyuki Isobe, Tomohito Tanihara, Yuya Yoshida und 11 weitere

Investigative Ophthalmology & Visual Science · 17.06.2025 · 66 (6) · 56

DOI: 10.1167/iovs.66.6.56 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 17.06.2025. Verfasst von Rui Ji und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Vitreoretinopathy, Proliferative, Isoquinolines, Sulfonamides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitreoretinopathy, ProliferativeIsoquinolinesSulfonamidesAnimalsLiposomesRabbitsRetinal Pigment EpitheliumDisease Models, AnimalHumansEpithelial-Mesenchymal TransitionIntravitreal Injections

Substanzen

LiposomesK-115IsoquinolinesSulfonamides

Autor:innen und Institutionen

  • Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
  • Tokyo New Drug Research Laboratories, Kowa Company, Ltd., Tokyo, Japan.
  • Department of Drug Discovery Structural Analysis, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
  • DDS Strategy Firm, Tokyo, Japan.
  • Department of Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan.

Förderung

  • NEI NIH HHS

Zitieren

APA

Ji, R., Ishikawa, K., Tan, W., Mori, K., Tsukamoto, R., Matsunaga, N., Kiyohara, K., Fukuda, Y., Wada, I., Isobe, T., Tanihara, T., Yoshida, Y., Mayanagi, K., Oyama, K., Terada, Y., Otsuki, K., Hamamura, K., Kikuchi, H., Nakao, S., …, & Sonoda, K. H. (2025). Liposome Encapsulation Enhances Ripasudil Therapeutic Efficacy Against Proliferative Vitreoretinal Diseases: Implications in Advanced Ocular Treatment. Investigative Ophthalmology & Visual Science, 66(6), 56. https://doi.org/10.1167/iovs.66.6.56

Vancouver

Ji R, Ishikawa K, Tan W, Mori K, Tsukamoto R, Matsunaga N, et al. Liposome Encapsulation Enhances Ripasudil Therapeutic Efficacy Against Proliferative Vitreoretinal Diseases: Implications in Advanced Ocular Treatment. Investigative Ophthalmology & Visual Science. 2025;66(6):56. doi:10.1167/iovs.66.6.56

BibTeX
@article{Ji2025,
  author = {Ji, Rui and Ishikawa, Keijiro and Tan, Wei and Mori, Kenichiro and Tsukamoto, Ryotaro and Matsunaga, Naoya and Kiyohara, Kohei and Fukuda, Yosuke and Wada, Iori and Isobe, Tomoyuki and Tanihara, Tomohito and Yoshida, Yuya and Mayanagi, Kouta and Oyama, Kosuke and Terada, Yuma and Otsuki, Kaita and Hamamura, Kengo and Kikuchi, Hiroshi and Nakao, Shintaro and Yoshida, Shigeo and Kannan, Ram and Ohdo, Shigehiro and Sonoda, Koh-Hei},
  title = {Liposome Encapsulation Enhances Ripasudil Therapeutic Efficacy Against Proliferative Vitreoretinal Diseases: Implications in Advanced Ocular Treatment},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  volume = {66},
  number = {6},
  pages = {56},
  doi = {10.1167/iovs.66.6.56}
}
Kostenlos starten →